Diabetic Neuropathies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2013-01-17
EMA Withdrawn: Duloxetine Boehringer Ingelheim (duloxetine) — Boehringer Ingelheim International GmbH
Duloxetine (Boehringer Ingelheim) product withdrawn from the market.